OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9807	Companies
196740	Keywords
127751	Articles
104600	Press releases

Home
Companies
OXURION

BRIEF

published on 07/03/2025 at 18:05, 7 months 1 day ago

Oxurion annonce des changements dans son actionnariat grâce à Atlas Special Opportunities

Actionnariat Transparence Legislation Oxurion Opportunités Spéciales Atlas
PRESS RELEASE

published on 07/03/2025 at 18:00, 7 months 1 day ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications, crossing under thresholds due to selling of voting securities. Company combines therapeutic innovation with clinical research technologies

Clinical Research Oxurion NV Therapeutic Innovation Transparency Notifications Voting Securities
PRESS RELEASE

published on 07/03/2025 at 18:00, 7 months 1 day ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV (Euronext Brussel: OXUR) annonce des notifications de transparence conformément à la législation belge. Atlas Special Opportunities II LLC a réduit sa participation en dessous des seuils de 5% et 3%

Actions Transparence Belgique Oxurion NV Atlas Special Opportunities II LLC
BRIEF

published on 06/30/2025 at 18:05, 7 months 4 days ago

Oxurion Reports Transparency Notification from Atlas Special Opportunities

Transparency Notification Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
BRIEF

published on 06/30/2025 at 18:05, 7 months 4 days ago

Oxurion publie une notification de transparence d'Atlas Special Opportunities

Actionnariat Biopharmaceutique Notification De Transparence Oxurion Opportunités Spéciales Atlas
PRESS RELEASE

published on 06/30/2025 at 18:00, 7 months 4 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC as it crosses under 10% shareholding threshold by selling voting securities. Company focused on therapeutic innovation and clinical research technologies

Clinical Research Transparency Notification Biopharmaceutical Belgium Oxurion NV
PRESS RELEASE

published on 06/30/2025 at 18:00, 7 months 4 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen. Bedrijf combineert therapeutische innovatie met klinisch onderzoekstechnologieën

Transparantiekennisgeving Oxurion NV België Biofarmaceutisch Bedrijf Atlas Special Opportunities II LLC
BRIEF

published on 06/25/2025 at 18:05, 7 months 9 days ago

Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC

Actions Notification Transparence Atlas Special Opportunities Oxurion
BRIEF

published on 06/25/2025 at 18:05, 7 months 9 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 06/25/2025 at 18:00, 7 months 9 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen en onder drempel van 15% gegaan. Bedrijf richt zich op therapeutische innovatie met technologieën voor klinisch onderzoek

Transparantiekennisgeving Aandelen Oxurion NV Atlas Special Opportunities II LLC Therapeutische Innovatie

Accesswire

Published on 02/05/2026 at 12:00, 37 minutes ago

Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026
Published on 02/05/2026 at 09:05, 3 hours 32 minutes ago

BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 11 hours 2 minutes ago

Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 12 hours 37 minutes ago

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 14 hours 12 minutes ago

55 North Mining Announces Flow-Through Financing

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 11:47, 50 minutes ago

Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE
Published on 02/05/2026 at 11:46, 50 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 02/05/2026 at 11:45, 51 minutes ago

EQS-WpÜG: Takeover Offer / Target company: Klöckner & Co SE; Bidder: Worthington Steel GmbH
Published on 02/05/2026 at 11:42, 54 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 02/05/2026 at 11:30, 1 hour 7 minutes ago

Linde Reports Full-Year and Fourth-Quarter 2025 Results (Earnings Release Tables Attached)

Les Echos

Published on 02/05/2026 at 11:30, 1 hour 7 minutes ago

Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 1 hour 7 minutes ago

Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 18 hours 32 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 18 hours 32 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 18 hours 52 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31

View all LES ECHOS COMFI WIRE